Introducing OptiLight: the first FDA-approved IPL solution for dry eye disease caused by MGD

Lumenis, the inventor of IPL, presents the first and only IPL FDA-approved and TGA-listed for the management of dry eye disease due to MGD. OptiLight elevates dry eye management with Lumenis’ patented Optimal Pulse Technology (OPT™) and user-centered design. Get the safe, precise, elegant procedure you want and the comfortable, effective therapy your patients need to manage dry eye disease with OptiLight. READ MORE